Addressing Treatment Fatigue: Long-Acting Growth Hormone for the Pediatric Patient with GH Deficiency

Wednesday, July 13, 2022

PROGRAM FEATURES

• 1.0 CME Credits
• Interactive, Case-Based Learning
• Complimentary Personalized Online Poster Portal
• Whiteboard Animations

PROGRAM DESCRIPTION

This educational virtual symposium will help healthcare providers caring for pediatric patients to promptly diagnose childhood growth hormone deficiency. The program will address the challenges faced by both caregivers and patients in regard to daily administration of growth hormone and will provide clinical data on long-acting growth hormone preparations for the chronic treatment of patients with CGHD.

 FACULTY

	Andrew Dauber, MD MMSc Chief of Endocrinology Children’s National Hospital Washington, DC
	Bradley S. Miller, MD, PhD Director, Division of Endocrinology Professor, Department of Pediatrics M Health Fairview Masonic Children’s Hospital University of Minnesota Medical School Minneapolis, Minnesota

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Describe the clinical workup including presentation, genetic and laboratory findings to diagnosis the pediatric patient with growth hormone deficiency
• Review current therapies for the treatment of CGHD and their accompanying persistence and adherence challenges in the pediatric population
• Evaluate available and emerging long-acting growth hormone (LAGH) compounds’ clinical data, efficacy and safety, in the chronic management of children with GHD
• Discuss personalized strategies with LAGH preparations for patients with CGHD to optimize patient-centered outcomes

TARGET AUDIENCE

This educational activity is intended for US-based pediatric endocrinologists, endocrinologists, endocrine fellows, pediatricians, physician’s assistants, nurse practitioners, and healthcare professionals who diagnose and manage CGHD.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

This program would be beneficial for nurses involved in the treatment of patients with childhood growth hormone deficiency.

CNE Credits: 1.0 ANCC Contact Hour

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

 DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

 AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs.  Please contact Med Learning Group prior to participating at [email protected]